Epithelial Nuclear Factor-κB Activation in Inflammatory Bowel Diseases and Colitis-Associated Carcinogenesis

By  

Digestion, Vol. 93, Iss. 1, 2016-0 ,pp. : 40-46

Karger

Access to resources Recommend Favorite

Nuclear factor-κB activation by type II collagen peptide in articular chondrocytes: its inhibition by hyaluronan via the receptors

By Yasuda Tadashi  

Modern Rheumatology, Vol. 23, Iss. 6, 2013-11 ,pp. : 1116-1123

Springer Publishing Company

Access to resources Recommend Favorite

Expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand (RANKL) in HCC70 breast cancer cells and effects of treatment with gonadotropin-releasing hormone on RANKL expression

By Schubert Antje   Schulz Hiltrud   Emons Gunter   Grundker Carsten  

Gynecological Endocrinology, Vol. 24, Iss. 6, 2008-01 ,pp. : 331-338

Informa Healthcare

Access to resources Recommend Favorite

CD40 expression on human pancreatic duct cells: role in nuclear factor-kappa B activation and production of pro-inflammatory cytokines

By Vosters O.   Beuneu C.   Nagy N.   Movahedi B.   Aksoy E.   Salmon I.   Pipeleers D.   Goldman M.   Verhasselt V.  

Diabetologia, Vol. 47, Iss. 4, 2004-04 ,pp. : 660-668

Springer Publishing Company

Access to resources Recommend Favorite

Soluble receptor activator of nuclear factor-κB ligand (RANKL) and osteoprotegerin in ankylosing spondylitis: OPG is associated with poor physical mobility and reflects systemic inflammation

By Chen Chun-Hsiung   Chen Hung-An   Liao Hsien-Tzung   Liu Chin-Hsiu   Tsai Chang-Youh   Chou Chung-Tei  

Clinical Rheumatology, Vol. 29, Iss. 10, 2010-10 ,pp. : 1155-1161

Springer Publishing Company

Access to resources Recommend Favorite